Curtiss-Wright enters its May 7 Q1 earnings call having done something its options market hadn't managed in months: turned decisively bullish.
The clearest setup this week is in options. The put/call ratio dropped to 0.86 on Tuesday — more than 2.4 standard deviations below its 20-day average of 1.19 and the most call-heavy reading the stock has produced in the past year. For most of April, the PCR held above 1.10, consistent with defensive hedging. That overhang has now cleared with force, suggesting options traders shifted from protection to positioning ahead of tomorrow's report.
Short interest tells a much less dramatic story, and the contrast is worth naming. Bears hold just 1.6% of the free float short — not a meaningful directional signal on its own. That position has grown about 15% over the past month in share terms, from roughly 498,000 to 580,000 shares, but in the context of a $25 billion-plus enterprise value, it amounts to background noise. Cost to borrow is essentially flat at 0.42%, and availability in the lending market remains extremely loose — nowhere near the tightness that would suggest squeeze risk or conviction from short sellers. The ORTEX short score of 30 sits well below the midpoint of its 0-100 scale, reinforcing the picture of limited bearish engagement.
The Street's positioning carries its own tension. Analysts who cover the stock have been raising targets steadily — Stifel moved its number to $723 on April 14, up from $650, while Citigroup went to $728 shortly before that. Both firms remain at Hold or Neutral, however, which captures the broader dynamic: the upgrades reflect recognition of what has already happened rather than conviction on fresh upside. The consensus mean target of roughly $728 aligns almost exactly with the current price of $728.95, leaving essentially zero implied upside from the Street's central case. The PE multiple has expanded to 46.6x over the past month, and EV/EBITDA is running near 32x — valuation that prices in continued execution. The bull case rests on a Defence Electronics segment that posted 17.5% year-on-year revenue growth, a 14% EPS beat last quarter, and $176 million in free cash flow with a 137% conversion rate. The bear case centres on order timing risk — $50 million in orders slipped out of Q3 2025 due to continuing resolution uncertainty — and the revenue recognition profile that management has flagged as subject to compression.
Peers had a split week, underscoring the selectivity in defence. HII fell nearly 10% in a single session Wednesday and is down about 10% on the week; BWXT shed close to 8% over the same period. MRCY, by contrast, gained more than 8% on the week. CW's 3.2% gain into earnings sits in the constructive middle of the pack — neither a momentum chase nor a warning sign.
The most recent comparable earnings print, Q4 2025 reported in February, produced a 7.9% one-day gain and a 10.8% five-day gain. Q1 2026 saw a 2% move the following day, but that event data may reflect pre-announcement news flow rather than a standard release. With the PCR flipping sharply to the call side the day before the report, what to watch is whether the revenue growth rate in Defence Electronics holds its trajectory — and whether any further commentary on order-book timing calms or stokes the bears' remaining concerns about visibility.
See the live data behind this article on ORTEX.
Open CW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
